Press release
Omisirge Market Analysis Reveals Trends in Changing Industry Demand
Omisirge Market Size
Forecasted Expansion and Market Size Trends for Omisirge by 2030
The historical growth in the Omisirge market has been propelled by the rising cases of hematologic cancers, the shortcomings of traditional cord blood transplantation methods, early favorable clinical trial results for cell expansion technologies, increased use of allogeneic stem cell transplants, and regulatory clearances for advanced cell therapies. Looking ahead, the forecast period anticipates further expansion driven by the broadening of personalized cell therapy portfolios, growing investments in regenerative medicine, wider adoption of cutting-edge transplantation protocols, an intensified focus on minimizing post-transplant complications, and the scaling up of cell therapy manufacturing infrastructure. Key trends shaping the market include a rising acceptance of expanded cord blood therapies, the increased use of ex vivo cell expansion processes, a commitment to faster neutrophil engraftment, the growth of allogeneic hematopoietic stem cell transplantation (HSCT) applications, and enhanced manufacturing scalability for cell-based therapies.
Download a free sample of the omisirge market report:
https://thebusinessresearchcompany.com/sample_request?id=85935038&type=smp&name=Omisirge%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Sep_PR
Principal Players Commanding the Omisirge Market Sphere
One major entity leading the Omisirge market is Gamida Cell Ltd. In a significant development from March 2025, Ayrmid Pharma Ltd., a US-based firm specializing in nicotinamide-enhanced allogeneic progenitor cell therapies, formed a strategic partnership with RoslinCT. This collaboration aims to boost manufacturing capabilities and support the scalable production of Omisirge (omidubicel-only). By transferring technology and enabling manufacturing at RoslinCT's Hopkinton, Massachusetts facility, Ayrmid Pharma secures a dual sourcing strategy that enhances supply reliability and commercial-scale production. RoslinCT, headquartered in Scotland, is a contract development and manufacturing organization (CDMO) offering process development, analytical services, and GMP manufacturing for advanced cell and gene therapies.
Key Market Trends Positively Influencing Omisirge Growth
Companies within the Omisirge market are heavily invested in advancing technology like omidubicel-only to improve transplant success and patient recovery. Omidubicel-only is an allogeneic stem cell therapy derived from umbilical cord blood, engineered specifically to boost cell expansion for quicker engraftment. A landmark moment occurred in May 2023 when the U.S. Food and Drug Administration approved Gamida Cell's Omisirge product. This therapy aims to enhance stem cell engraftment and reduce infection risks for transplant recipients. The FDA's approval introduced a superior expanded cord blood-derived cell therapy designed to speed neutrophil recovery and decrease infection chance in patients with hematologic malignancies. Compared with conventional cord blood transplants, Omisirge offers a more dependable engraftment profile, making transplant procedures both faster and safer clinically.
View the full omisirge market report:
https://thebusinessresearchcompany.com/report/omisirge-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Sep_PR
Breakdown of Omisirge Market Segmentation
The Omisirge market is organized into several segments for analytical clarity:
1) Clinical Indication: Leukemia, Lymphoma, Myeloma, and other hematologic malignancies
2) Distribution Channel: Direct sales and distributors
3) End User: Hospitals and clinics as well as ambulatory surgical centers
This segmentation highlights how the market addresses different disease types, sales pathways, and healthcare settings, providing a comprehensive view of Omisirge's positioning in the advanced cell therapy landscape.
Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Omisirge Market Analysis Reveals Trends in Changing Industry Demand here
News-ID: 4624054 • Views: …
More Releases from The Business Research Company
Plegridy Market Analysis Reveals Changes in Industry Demand Trends
Exploring the Outlook for the Plegridy Market Through 2030
The Plegridy market has experienced significant growth in recent years, driven largely by a rise in multiple sclerosis (MS) diagnoses and the increased availability of interferon-based treatments. Additionally, the expansion of specialized neurology clinics, a surge in injectable biologic therapies, and regulatory approvals of pegylated drugs have all contributed to the market's upward trajectory during this historical period.
Key Factors Supporting…
Plasbumin-25 Market Report Analyzes Industry Trends, Key Growth Factors, and Fut …
The Plasbumin-25 market is witnessing steady growth driven by its critical role in treating various medical conditions, especially in intensive care settings. As the demand for advanced therapies rises, this segment is poised to expand significantly through the coming years. Understanding its current status, key drivers, major players, and market segments helps to paint a comprehensive picture of future prospects.
Projected Market Size and Growth Trajectory of the Plasbumin-25 Industry …
Pertzye Market Outlook Reveals Key Strategic Opportunities Within the Industry
An Overview of Pertzye Market Growth and Dynamics
The Pertzye market is poised for substantial expansion, driven by evolving medical practices and increasing awareness of digestive health conditions. With advancements in enzyme therapies and broader treatment protocols, the market is witnessing significant momentum that is expected to continue well into the next decade.
Historical Growth Factors Influencing the Pertzye Market
The market's development during the past years is largely…
Pergonal Market Report Analyzes Top Companies and Expansion Prospects
The Pergonal market is gaining increasing attention as infertility concerns grow and fertility treatment options become more accessible. With advancements in reproductive healthcare and personalized therapies, this market is set to experience notable growth in the coming years. Let's explore the current valuation outlook, key factors driving expansion, dominant players, and detailed segment analysis within the Pergonal industry.
Projected Market Valuation of the Pergonal Market by 2030
The rise in…
More Releases for Omisirge
Anemia Market to Grow at a Significant CAGR Across the 7MM Through 2036 | DelveI …
DelveInsight's "Anemia Market Insights, Epidemiology, and Market Forecast - 2036" report delivers an in-depth understanding of the Anemia, historical and forecasted epidemiology and the Anemia market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Explore the intricate details of the Anemia Market Report @ https://www.delveinsight.com/report-store/anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr
Key Takeaways from Anemia Market Report
• In April 2026, Johnson & Johnson announced that the US FDA…
Anemia Therapeutics Market Size in the 7MM is projected to grow at a significant …
DelveInsight's 'Anemia Market Insights, Epidemiology and Market Forecast - 2036' report delivers an in-depth understanding of the Anemia, historical and forecasted epidemiology, as well as the Anemia market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Explore the intricate details of the Anemia Treatment Market Report @ https://www.delveinsight.com/sample-request/anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=yash
Key Takeaways from the Anemia Market Report
• In April 2026, Johnson & Johnson announced that…
Aplastic Anemia Market to Witness Strong Growth and Significant Market Expansion …
DelveInsight's "Aplastic Anemia Market Insights, Epidemiology, and Market Forecast-2036′′ report offers an in-depth understanding of the Aplastic Anemia, historical and forecasted epidemiology as well as the Aplastic Anemia market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Get a Free sample for the Aplastic Anemia Market Report
https://www.delveinsight.com/sample-request/aplastic-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gaurav
Some of the key facts of the Aplastic Anemia Market Report:
• The Acromegaly market size…
Segmentation, Major Trends, and Competitive Overview of the Omisirge Market
The Omisirge market is poised for significant growth as advancements in cell therapy and regenerative medicine continue to gain momentum. With increasing investments and technological innovations, the market is expected to expand steadily, driven by improved transplantation protocols and enhanced manufacturing capabilities. Below, we explore the market size forecast, key industry players, current trends, and segmentation details shaping the future of Omisirge.
Long-Term Growth Outlook for the Omisirge Market Size Through…
Aplastic Anemia Treatment Market Size (7MM) was ~USD 270 million in 2023, and it …
DelveInsight's "Aplastic Anemia Treatment Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Aplastic Anemia, historical and forecasted epidemiology, as well as the Aplastic Anemia market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover which therapies are expected to grab the Aplastic Anemia Market Share @ Aplastic Anemia Market Outlook- https://www.delveinsight.com/sample-request/aplastic-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Aplastic…
Impact Of Rising Chronic Diseases On The Growth Of The Market : An Emerging Driv …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Omisirge Market?
In recent years, the market size of omisirge has seen an XX (HCAGR) growth. The market, valued at $XX million in 2024, is projected to see an increase to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. This…
